APOBEC3D anticorps (AA 250-371) (FITC)

N° du produit ABIN7150154

Détail du produit anti-APOBEC3D anticorps (FITC)

Antigène: APOBEC3D (Apolipoprotein B mRNA Editing Enzyme, Catalytic Polypeptide-Like 3D (APOBEC3D))

Épitope: AA 250-371

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp APOBEC3D est conjugé à/à la FITC

Application: Veuillez nous consulter SVP

Réactivité croisée: Humain

Purification: >95%, Protein G purified

Immunogène: Recombinant Human DNA dC->dU-editing enzyme APOBEC-3D protein (250-371AA)

Isotype: IgG

Information d'application

Restrictions: For Research Use only

Stockage

Format: Liquid

Buffer: Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, pH 7.4

Agent conservateur: ProClin

Précaution d'utilisation: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: -20 °C,-80 °C

Stockage commentaire: Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.

Détails sur APOBEC3D

Antigène: APOBEC3D (Apolipoprotein B mRNA Editing Enzyme, Catalytic Polypeptide-Like 3D (APOBEC3D))

Autre désignation: APOBEC3D (APOBEC3D Produits)

Synonymes: anticorps A3D, anticorps APOBEC3DE, anticorps APOBEC3E, anticorps ARP6, anticorps APOBEC3D, anticorps apolipoprotein B mRNA editing enzyme catalytic subunit 3D, anticorps APOBEC3D

Sujet:

Background: DNA deaminase (cytidine deaminase) which acts as an inhibitor of retrovirus replication and retrotransposon mobility via deaminase-dependent and -independent mechanisms. Exhibits antiviral activity against vif-deficient HIV-1. After the penetration of retroviral nucleocapsids into target cells of infection and the initiation of reverse transcription, it can induce the conversion of cytosine to uracil in the minus-sense single-strand viral DNA, leading to G-to-A hypermutations in the subsequent plus-strand viral DNA. The resultant detrimental levels of mutations in the proviral genome, along with a deamination-independent mechanism that works prior to the proviral integration, together exert efficient antiretroviral effects in infected target cells. Selectively targets single-stranded DNA and does not deaminate double-stranded DNA or single-or double-stranded RNA. May inhibit the mobility of LTR and non-LTR retrotransposons.

Aliases: A3D antibody, ABC3D_HUMAN antibody, APOBEC3D antibody, APOBEC3DE antibody, APOBEC3E antibody, Apolipoprotein B mRNA editing enzyme catalytic polypeptide like 3D antibody, Apolipoprotein B mRNA editing enzyme catalytic polypeptide like 3E pseudogene antibody, ARP6 antibody, bK150C2.9 antibody, BK150C2.9 protein antibody, DNA dC >dU editing enzyme APOBEC 3D antibody, DNA dC->dU-editing enzyme APOBEC-3D antibody, hCG_41704 antibody, HCG41704, isoform CRA_b antibody, Probable DNA dC->dU-editing enzyme APOBEC-3D antibody

UniProt: Q96AK3